We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.06B
AUM Growth
-$1.38M
Cap. Flow
+$20.5M
Cap. Flow %
1.94%
Top 10 Hldgs %
7.1%
Holding
774
New
159
Increased
222
Reduced
220
Closed
120

Top Buys

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$5.67M
2
SOFI icon
SoFi Technologies
SOFI
+$5.22M
3
TRU icon
TransUnion
TRU
+$4.01M
4
EXPE icon
Expedia Group
EXPE
+$3.93M
5
CNMD icon
CONMED
CNMD
+$3.78M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$7.81M
2
SWK icon
Stanley Black & Decker
SWK
+$5.62M
3
KMX icon
CarMax
KMX
+$4.41M
4
SG icon
Sweetgreen
SG
+$4.23M
5
MU icon
Micron Technology
MU
+$4.08M

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Healthcare 19.51%
3 Industrials 14.23%
4 Consumer Discretionary 11.24%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTDR icon
251
Frontdoor
FTDR
$5.1B
$1.56M 0.15%
46,131
+5,100
+12% +$172K
FHN icon
252
First Horizon
FHN
$12.1B
$1.56M 0.15%
98,752
-53,148
-35% -$805K
NYT icon
253
New York Times
NYT
$11.7B
$1.55M 0.15%
30,239
+9,739
+48% +$458K
SITM icon
254
SiTime
SITM
$15.7B
$1.55M 0.15%
12,449
+4,104
+49% +$438K
LEVI icon
255
Levi Strauss
LEVI
$9.83B
$1.53M 0.14%
79,114
-388
-0.5% -$8.5K
FIP icon
256
FTAI Infrastructure
FIP
$490M
$1.52M 0.14%
+176,127
New +$1.34M
RCL icon
257
Royal Caribbean
RCL
$81.8B
$1.51M 0.14%
+9,500
New +$1.37M
RKT icon
258
Rocket Companies
RKT
$38.2B
$1.51M 0.14%
110,272
-475
-0.4% -$6.42K
BIIB icon
259
Biogen
BIIB
$29.5B
$1.51M 0.14%
+6,500
New +$1.41M
CYBR
260
DELISTED
CyberArk
CYBR
$1.5M 0.14%
5,503
-2,497
-31% -$613K
PAYO icon
261
Payoneer
PAYO
$2.41B
$1.5M 0.14%
271,431
+3,202
+1% +$17.3K
DCH
262
Dauch Corp
DCH
$1.32B
$1.49M 0.14%
213,649
+63,863
+43% +$471K
KVYO icon
263
Klaviyo
KVYO
$5.31B
$1.48M 0.14%
+59,598
New +$1.39M
RLAY icon
264
Relay Therapeutics
RLAY
$4.06B
$1.48M 0.14%
226,632
+73,641
+48% +$503K
FERG icon
265
Ferguson
FERG
$45.4B
$1.48M 0.14%
7,622
-2,400
-24% -$503K
NTCT icon
266
NETSCOUT
NTCT
$2.86B
$1.46M 0.14%
+80,062
New +$1.58M
VIR icon
267
Vir Biotechnology
VIR
$1.48B
$1.46M 0.14%
+164,327
New +$1.58M
UHS icon
268
Universal Health Services
UHS
$9.64B
$1.45M 0.14%
+7,842
New +$1.39M
CRS icon
269
Carpenter Technology
CRS
$28.8B
$1.45M 0.14%
13,215
+89
+0.7% +$8.55K
PEN icon
270
Penumbra
PEN
$12.6B
$1.44M 0.14%
7,995
+6,474
+426% +$1.29M
GT icon
271
Goodyear
GT
$2.04B
$1.44M 0.14%
+126,464
New +$1.55M
REPL icon
272
Replimune Group
REPL
$724M
$1.43M 0.14%
+158,770
New +$1.11M
MEOH icon
273
Methanex
MEOH
$4.19B
$1.41M 0.13%
29,174
-188
-0.6% -$9.37K
NRIX icon
274
Nurix Therapeutics
NRIX
$2.43B
$1.4M 0.13%
67,224
-26
-0% -$405
PRM icon
275
Perimeter Solutions
PRM
$5.44B
$1.4M 0.13%
178,673
-282
-0.2% -$2.11K

Similar funds

PDT Partners's Q2 2024 Portfolio in Review

As of Q2 2024, PDT Partners held 774 positions worth $1.06B, down 0.13% from $1.06B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

PDT Partners's Q2 2024 filing shows 159 new, 222 increased, 220 reduced and 120 closed positions. Its largest new stake was SoFi Technologies: 740,850 shares worth $4.9M. The largest sale was Ferrari, an estimated $7.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • PDT Partners's largest Q2 2024 buy was SoFi Technologies: 740,850 shares worth $4.9M.
  • PDT Partners added most to 10x Genomics in Q2 2024, an estimated $5.67M increase.
  • PDT Partners's biggest Q2 2024 reduction was Ferrari, cutting an estimated $7.81M.
  • PDT Partners fully exited CarMax in Q2 2024, selling an estimated $4.41M.
  • PDT Partners's ten largest holdings make up 7.1% of its $1.06B portfolio in Q2 2024.
  • PDT Partners opened 159 new positions and closed 120 in Q2 2024.
  • PDT Partners's portfolio value fell 0.13% quarter-over-quarter to $1.06B.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.